Compile Data Set for Download or QSAR
Report error Found 91 Enz. Inhib. hit(s) with all data for entry = 13112
TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759899(US20250236609, Example 4)
Affinity DataIC50: 100nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759932(US20250236609, Example 37)
Affinity DataIC50: 100nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759897(US20250236609, Example 2)
Affinity DataIC50: 100nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759929(US20250236609, Example 34)
Affinity DataIC50: 100nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759896(US20250236609, Example 1)
Affinity DataIC50: 100nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759939(US20250236609, Example 44)
Affinity DataIC50: 100nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759937(US20250236609, Example 42)
Affinity DataIC50: 100nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759969(US20250236609, Example 77)
Affinity DataIC50: 100nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759933(US20250236609, Example 38)
Affinity DataIC50: 100nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759965(US20250236609, Example 72)
Affinity DataIC50: 100nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759975(US20250236609, Example 84)
Affinity DataIC50: 100nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759912(US20250236609, Example 17)
Affinity DataIC50: 100nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759976(US20250236609, Example 85)
Affinity DataIC50: 100nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759909(US20250236609, Example 14)
Affinity DataIC50: 100nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759973(US20250236609, Example 82)
Affinity DataIC50: 100nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759942(US20250236609, Example 49)
Affinity DataIC50: 100nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759923(US20250236609, Example 28)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759985(US20250236609, Example 96)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759921(US20250236609, Example 26)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759986(US20250236609, Example 97)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759922(US20250236609, Example 27)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759919(US20250236609, Example 24)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759920(US20250236609, Example 25)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759917(US20250236609, Example 22)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759927(US20250236609, Example 32)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759925(US20250236609, Example 30)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759938(US20250236609, Example 43)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759936(US20250236609, Example 41)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759941(US20250236609, Example 48)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759900(US20250236609, Example 5)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759898(US20250236609, Example 3)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759959(US20250236609, Example 66)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759907(US20250236609, Example 12)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759971(US20250236609, Example 79)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759905(US20250236609, Example 10)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759970(US20250236609, Example 78)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759903(US20250236609, Example 8)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759904(US20250236609, Example 9)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759968(US20250236609, Example 76)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759902(US20250236609, Example 7)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759915(US20250236609, Example 20)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759913(US20250236609, Example 18)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759977(US20250236609, Example 86)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759978(US20250236609, Example 87)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759911(US20250236609, Example 16)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759910(US20250236609, Example 15)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759974(US20250236609, Example 83)
Affinity DataIC50: 300nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759924(US20250236609, Example 29)
Affinity DataIC50: 750nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759940(US20250236609, Example 47)
Affinity DataIC50: 750nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

TargetPhosphatidylinositol 3-kinase catalytic subunit type 3(Human)
Deciphera Pharmaceuticals

US Patent
LigandPNGBDBM759935(US20250236609, Example 40)
Affinity DataIC50: 750nMAssay Description:Activity of VPS34 kinase was determined using an ADP-Glo kinase activity assay (Promega Corp). Assays were conducted in 384-well plates (5 μL assay v...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Displayed 1 to 50 (of 91 total ) | Next | Last >>
Jump to: